Skip to content
Disclosery

QIMING U.S. VENTURES MANAGEMENT, LLC

Follow

13F filer, CIK 1909617, BELLEVUE, WA

QIMING U.S. VENTURES MANAGEMENT, LLC reported $55,636,803 across 4 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-10.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001909617-25-000004

Period
2025-09-30
Reported value
$55.6M
Holdings
4
Top 10 weight
100%
New
0
Sold out
2

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
VTYXexited-412,225-$882K
HILLEVAX INCexited-372,615-$742K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0001909617-25-000004, largest first. % of portfolio is the value over $55,636,803, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
Tourmaline Bio IncTourmaline Bio IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: 641,691 shares; 2024Q1: 741,691 shares; 2024Q2: 741,691 shares; 2024Q3: 741,691 shares; 2024Q4: 741,691 shares; 2025Q1: 741,691 shares; 2025Q2: 741,691 shares; 2025Q3: 741,691 shares 741,691$35.5M63.76%0
KRROKORRO BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: 368,085 shares; 2024Q1: 368,085 shares; 2024Q2: 368,085 shares; 2024Q3: 368,085 shares; 2024Q4: 368,085 shares; 2025Q1: 368,085 shares; 2025Q2: 368,085 shares; 2025Q3: 368,085 shares 368,085$17.6M31.68%0Timeline
JSPRJASPER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: not reported; 2024Q1: 928,964 shares; 2024Q2: 928,964 shares; 2024Q3: 928,964 shares; 2024Q4: 928,964 shares; 2025Q1: 928,964 shares; 2025Q2: 928,964 shares; 2025Q3: 928,964 shares 928,964$2.21M3.97%0Timeline
KZRKEZAR LIFE SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: not reported; 2024Q1: not reported; 2024Q2: not reported; 2024Q3: not reported; 2024Q4: 82,871 shares; 2025Q1: 82,871 shares; 2025Q2: 82,871 shares; 2025Q3: 82,871 shares 82,871$323K0.58%0Timeline

Sold out in Q3 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
VTYXVENTYX BIOSCIENCES INC412,225$882Kshares
HILLEVAX INCHILLEVAX INC372,615$742Kshares

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001909617-25-000004 base2025-11-10acceptance time not in the bulk data set